Amicrobe, Inc. — Form D
Amicrobe, Inc. of CARLSBAD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-25
- Form: D
- Accession: 0001723008-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 51
- Date of first sale: 2013-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-511583
Issuer
- Name: Amicrobe, Inc.
- CIK: 0001513330
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 3142 TIGER RUN COURT, CARLSBAD, CA, 92010
- Phone: 888-490-1180
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Albert Carnesale | Director | Carlsbad, CA |
| Michael Bevilacqua | Director | Carlsbad, CA |
| Michael Bevilacqua | Executive Officer | Carlsbad, CA |
| Michael Flesch | Director | Carlsbad, CA |
| Michael Flesch | Executive Officer | Carlsbad, CA |
| Martin Burns | Director | Carlsbad, CA |
| Daniel Huang | Executive Officer | Carlsbad, CA |
| Joseph Boystak | Director | New York, NY |
| Joseph Boystak | Executive Officer | New York, NY |
| Scott Hayashi | Executive Officer | Pasadena, CA |
Other filings by this issuer (2)
More